New immunotherapeutic paradigms for castration-resistant prostate cancer

Lorenzo Galluzzi

doi:10.4161/onci.26084

New immunotherapeutic paradigms for castration-resistant prostate cancer

Research output: Contribution to journal › Editorial

11 Scopus citations

Original language	English
Article number	e26084
Journal	Oncoimmunology
Volume	2
Issue number	8
DOIs	https://doi.org/10.4161/onci.26084
State	Published - 2013
Externally published	Yes

Keywords

Ra
Alpharadin
Docetaxel
Provenge®
Sipuleucel-T
Xofigo®

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.4161/onci.26084

Cite this

@article{6332e1d35767401199717cb2f2a981df,

title = "New immunotherapeutic paradigms for castration-resistant prostate cancer",

keywords = "Ra, Alpharadin, Docetaxel, Provenge{\textregistered}, Sipuleucel-T, Xofigo{\textregistered}",

author = "Lorenzo Galluzzi",

year = "2013",

doi = "10.4161/onci.26084",

language = "English",

volume = "2",

journal = "Oncoimmunology",

issn = "2162-4011",

publisher = "Landes Bioscience",

number = "8",

}

TY - JOUR

T1 - New immunotherapeutic paradigms for castration-resistant prostate cancer

AU - Galluzzi, Lorenzo

PY - 2013

Y1 - 2013

KW - Ra

KW - Alpharadin

KW - Docetaxel

KW - Provenge®

KW - Sipuleucel-T

KW - Xofigo®

UR - http://www.scopus.com/inward/record.url?scp=84885786463&partnerID=8YFLogxK

U2 - 10.4161/onci.26084

DO - 10.4161/onci.26084

M3 - Editorial

AN - SCOPUS:84885786463

SN - 2162-4011

VL - 2

JO - Oncoimmunology

JF - Oncoimmunology

IS - 8

M1 - e26084

ER -

New immunotherapeutic paradigms for castration-resistant prostate cancer

Keywords

UN SDGs

Access to Document

Other files and links

Cite this